Key Sessions
Todd McDevitt
Keynote Panel Discussion- Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities
Genentech
Tadayuki Tanimura
Keynote Presentation: Bridging Science and Regulation - Lessons Learnt from Developing the World’s First iPSC-derived Cardiomyocyte Patches
Cuorips Inc.
Wednesday 23rd September - Conference Day One - ET (Eastern Time, GMT-05:00)
Wednesday 23rd September - Conference Day One
- ET (Eastern Time, GMT-05:00)
8:00am - 9:00am60 mins
Registration Break
Registration & Morning Coffee
9:00am - 10:30am90 mins
Workshop 1: Potency Masterclass
Potency Masterclass
- Christopher Bravery - Consulting Regulatory Scientist, Advbiols
9:00am - 10:30am90 mins
Workshop 2: Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
- James Blackwell - President and Principal Consultant, The Windshire Group, LLC
10:30am - 11:00am30 mins
Break
Morning Coffee Break
11:00am - 12:45pm105 mins
Workshop 1: Potency Masterclass
Potency Masterclass
- Christopher Bravery - Consulting Regulatory Scientist, Advbiols
11:00am - 12:45pm105 mins
Workshop 2: Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
- James Blackwell - President and Principal Consultant, The Windshire Group, LLC
11:00am - 12:45pm105 mins
CGT: C-Level Forum
CGT: C-Level Forum
12:45pm - 1:00pm15 mins
Break
Transition To Lunch Presentations
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 1
Lunch Slot 1
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 2
Lunch Slot 2
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 3
Lunch Slot 3
1:45pm - 2:00pm15 mins
Break
Lunch Networking
2:00pm - 2:40pm40 mins
Keynote Plenary
Keynote Panel Discussion- Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities
- Todd McDevitt - Vice President, Cell Therapy, Genentech
- Tyler Koop - Vice President, Global Commercial, Cell Therapy, Bristol Myers Squibb
2:40pm - 3:20pm40 mins
Keynote Plenary
Investor Panel Discussion: Funding the Future- Investment Trends and Opportunities for Cell and Gene Therapies and Enabling Technologies
- Daniel Friedman - Managing Director, BroadOak Capital
- Laura Stoppel - Partner, RA Capital Management
- Christian Uhrich - Executive Investment Director, M Ventures
- Sebastien Latapie - Partner, AVANT BIO
3:20pm - 4:00pm40 mins
Keynote Plenary
Keynote Presentation: Bridging Science and Regulation - Lessons Learnt from Developing the World’s First iPSC-derived Cardiomyocyte Patches
- Tadayuki Tanimura - Executive Vice President, Cuorips Inc.
4:00pm - 5:00pm60 mins
Break
Afternoon Break and Grand Opening of the Exhibit Hall
5:00pm - 5:30pm30 mins
Exhibit Hall Roundtable Sessions
Exhibit Hall Roundtable Discussions
- Thorsten Gorba - VP, Process & Analytical Development, Aspen Neuroscience, Inc.
5:00pm - 5:30pm30 mins
CGT Live Labs Tour in Exhibit Hall
CGT Live Labs Tour in Exhibit Hall
5:30pm - 7:00pm90 mins
Break
Networking Drinks in the Exhibit & Poster Hall
7:00pm - 7:05pm5 mins
Break
End of Day One
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。